Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

FirstGroup unveils £50m buyback as full-year profits rise

(Sharecast News) - Train and bus operator FirstGroup has announced a new £50m buyback and said the outlook for the current year remains in line with expectations, though rail results will be lower due to South Western Railway (SWR) transferring into public ownership. While further adjusted operating profit progress is expected in the First Bus division over the 12 months to 29 March, helped by productivity, overhead and yield improvements, along with recent acquisitions, First Rail adjusted revenue and profit will be "marginally lower".

Lower fees are expected from SWR transferring into public ownership - was made official last month - while results will also be helped by normalising levels of variable fees from the Department for Transport.

The outlook came as FirstGroup delivered a small increase in annual adjusted revenues to £1.37bn from £1.28bn the year before, helped by a strong underlying First Bus performance, higher variable fees from the DfT and further growth in open access rail.

Adjusted pre-tax profit increased to £164.3m from £136.8m, with profit growth across both divisions.

The board proposed a final dividend of 4.8p per share, up from 4.0p last year and in line with its payout ratio, taking the full-year dividend to 6.5p from 6.0p.

The company also unveiled plans to return £50m to shareholders via a share repurchase programme, following £92m in buybacks in FY2025.

"Our positive cash generation and strong balance sheet allow us to capitalise on opportunities to grow our business as our industries transition, to maintain our progressive dividend policy and for further potential returns to shareholders," FirstGroup said.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.